The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Toradol     2-amino-2- (hydroxymethyl)propane-1,3- diol;...

Synonyms: Acuvail, Lixidol, Toratex, Acular, Syntex, ...
This record was replaced with 3826.
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of ketorolac


High impact information on ketorolac


Chemical compound and disease context of ketorolac


Biological context of ketorolac


Anatomical context of ketorolac


Associations of ketorolac with other chemical compounds


Gene context of ketorolac


Analytical, diagnostic and therapeutic context of ketorolac


  1. Parenteral ketorolac: the risk for acute renal failure. Feldman, H.I., Kinman, J.L., Berlin, J.A., Hennessy, S., Kimmel, S.E., Farrar, J., Carson, J.L., Strom, B.L. Ann. Intern. Med. (1997) [Pubmed]
  2. Ketorolac tromethamine-induced acute pancreatitis. Goyal, S.B., Goyal, R.S. Arch. Intern. Med. (1998) [Pubmed]
  3. Renal failure and hyperkalemia associated with ketorolac tromethamine. Pearce, C.J., Gonzalez, F.M., Wallin, J.D. Arch. Intern. Med. (1993) [Pubmed]
  4. Selective severe anaphylactic reaction due to ketorolac tromethamine without nonsteroidal anti-inflammatory drug intolerance. Scala, E., Giani, M., Pirrotta, L., Guerra, E.C., Locanto, M., De Pità, O., Puddu, P. J. Allergy Clin. Immunol. (2001) [Pubmed]
  5. Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Mulshine, J.L., Atkinson, J.C., Greer, R.O., Papadimitrakopoulou, V.A., Van Waes, C., Rudy, S., Martin, J.W., Steinberg, S.M., Liewehr, D.J., Avis, I., Linnoila, R.I., Hewitt, S., Lippman, S.M., Frye, R., Cavanaugh, P.F. Clin. Cancer Res. (2004) [Pubmed]
  6. Effects of the 2-amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid/kainate antagonist LY293558 on spontaneous and evoked postoperative pain. Gilron, I., Max, M.B., Lee, G., Booher, S.L., Sang, C.N., Chappell, A.S., Dionne, R.A. Clin. Pharmacol. Ther. (2000) [Pubmed]
  7. An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge. Buge, S.L., Richardson, E., Alipanah, S., Markham, P., Cheng, S., Kalyan, N., Miller, C.J., Lubeck, M., Udem, S., Eldridge, J., Robert-Guroff, M. J. Virol. (1997) [Pubmed]
  8. Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120. Kang, C.Y., Hariharan, K., Nara, P.L., Sodroski, J., Moore, J.P. J. Virol. (1994) [Pubmed]
  9. Effects of ketorolac tromethamine on hemostasis in volunteers. Conrad, K.A., Fagan, T.C., Mackie, M.J., Mayshar, P.V. Clin. Pharmacol. Ther. (1988) [Pubmed]
  10. Bone morphogenic proteins 2 and 4 and their receptors in the adult human cornea. Mohan, R.R., Kim, W.J., Mohan, R.R., Chen, L., Wilson, S.E. Invest. Ophthalmol. Vis. Sci. (1998) [Pubmed]
  11. Characterization of receptor subtypes involved in prostanoid-induced conjunctival pruritus and their role in mediating allergic conjunctival itching. Woodward, D.F., Nieves, A.L., Friedlaender, M.H. J. Pharmacol. Exp. Ther. (1996) [Pubmed]
  12. Hypochloremic alkalosis in infants associated with soy protein formula. Linshaw, M.A., Harrison, H.L., Gruskin, A.B., Prebis, J., Harris, J., Stein, R., Jayaram, M.R., Preston, D., DiLiberti, J., Baluarte, H.J., Elzouki, A., Carroll, N. J. Pediatr. (1980) [Pubmed]
  13. Topical ketorolac tromethamine 0.5% versus diclofenac sodium 0.1% to inhibit miosis during cataract surgery. Srinivasan, R., Madhavaranga, n.u.l.l. Journal of cataract and refractive surgery. (2002) [Pubmed]
  14. A randomized, double-blind, comparative study of the efficacy of ketorolac tromethamine versus meperidine in the treatment of severe migraine. Larkin, G.L., Prescott, J.E. Annals of emergency medicine. (1992) [Pubmed]
  15. Sublingual hyoscyamine sulfate in combination with ketorolac tromethamine for ureteral colic: a randomized, double-blind, controlled trial. Jones, J.B., Giles, B.K., Brizendine, E.J., Cordell, W.H. Annals of emergency medicine. (2001) [Pubmed]
  16. Clinical pharmacokinetics of ketorolac tromethamine. Brocks, D.R., Jamali, F. Clinical pharmacokinetics. (1992) [Pubmed]
  17. The effects on platelet aggregation and prostanoid biosynthesis of two parenteral analgesics: ketorolac tromethamine and dipyrone. Geisslinger, G., Peskar, B.A., Pallapies, D., Sittl, R., Levy, M., Brune, K. Thromb. Haemost. (1996) [Pubmed]
  18. Asthma caused by topical application of ketorolac. Sitenga, G.L., Ing, E.B., Van Dellen, R.G., Younge, B.R., Leavitt, J.A. Ophthalmology (1996) [Pubmed]
  19. Chiral kinetics and dynamics of ketorolac. Mroszczak, E., Combs, D., Chaplin, M., Tsina, I., Tarnowski, T., Rocha, C., Tam, Y., Boyd, A., Young, J., Depass, L. Journal of clinical pharmacology. (1996) [Pubmed]
  20. Effect of ketorolac on phagocytosis of Candida albicans by peritoneal macrophages. Fraser-Smith, E.B., Matthews, T.R. Immunopharmacology (1988) [Pubmed]
  21. Inhibition of some human neutrophil functions by the cyclooxygenase inhibitor ketorolac tromethamine. Hyers, T.M., Tricomi, S.M., Liao, J.J. J. Leukoc. Biol. (1992) [Pubmed]
  22. Ketorolac-induced acute renal failure and hyperkalemia: report of three cases. Haragsim, L., Dalal, R., Bagga, H., Bastani, B. Am. J. Kidney Dis. (1994) [Pubmed]
  23. Quantitative assessment of postsurgical breakdown of the blood-aqueous barrier following administration of 0.5% ketorolac tromethamine solution. A double-masked, paired comparison with vehicle-placebo solution study. Flach, A.J., Graham, J., Kruger, L.P., Stegman, R.C., Tanenbaum, L. Arch. Ophthalmol. (1988) [Pubmed]
  24. Effects on biliary tract pressure in humans of intravenous ketorolac tromethamine compared with morphine and placebo. Krimmer, H., Bullingham, R.E., Lloyd, J., Bruch, H.P. Anesth. Analg. (1992) [Pubmed]
  25. Pain relief after dental impaction surgery using ketorolac, hydrocodone plus acetaminophen, or placebo. Fricke, J., Halladay, S.C., Bynum, L., Francisco, C.A. Clinical therapeutics. (1993) [Pubmed]
  26. The morphine sparing effect of ketorolac tromethamine. A study of a new, parenteral non-steroidal anti-inflammatory agent after abdominal surgery. Gillies, G.W., Kenny, G.N., Bullingham, R.E., McArdle, C.S. Anaesthesia. (1987) [Pubmed]
  27. Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification: prospective randomized double-masked study. Holzer, M.P., Solomon, K.D., Sandoval, H.P., Vroman, D.T. Journal of cataract and refractive surgery. (2002) [Pubmed]
  28. Patient-controlled analgesia after arthroscopic rotator cuff repair: subacromial catheter versus intravenous injection. Cho, N.S., Ha, J.H., Rhee, Y.G. The American journal of sports medicine (2007) [Pubmed]
  29. Antinociceptive and neurotoxicologic screening of chronic intrathecal administration of ketorolac tromethamine in the rat. Korkmaz, H.A., Maltepe, F., Erbayraktar, S., Yilmaz, O., Güray, M., Canda, M.S., Günerli, A., Gökmen, N. Anesth. Analg. (2004) [Pubmed]
  30. Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction. Prospective randomized double-masked study. Solomon, K.D., Vroman, D.T., Barker, D., Gehlken, J. Journal of cataract and refractive surgery. (2001) [Pubmed]
  31. Immunomodulation with interleukin-10 and interleukin-4 compared with ketorolac tromethamine for prevention of postoperative adhesions in a murine model. Holschneider, C.H., Nejad, F., Montz, F.J. Fertil. Steril. (1999) [Pubmed]
  32. Effects of lysine clonixinate and ketorolac tromethamine on prostanoid release from various rat organs incubated ex vivo. Pallapies, D., Salinger, A., Meyer zum Gottesberge, A., Atkins, D.J., Rohleder, G., Nagyiványi, P., Peskar, B.A. Life Sci. (1995) [Pubmed]
  33. Acute reduction of renal 11 beta-hydroxysteroid dehydrogenase activity by several antinatriuretic stimuli. Riddle, M.C., McDaniel, P.A. Metab. Clin. Exp. (1993) [Pubmed]
  34. An inaccuracy in computed tomography: the energy dependence of CT values. Zatz, L.M., Alvarez, R.E. Radiology. (1977) [Pubmed]
  35. Topical 0.5% ketorolac vs 0.03% flurbiprofen for inhibition of miosis during cataract surgery. Solomon, K.D., Turkalj, J.W., Whiteside, S.B., Stewart, J.A., Apple, D.J. Arch. Ophthalmol. (1997) [Pubmed]
  36. Peripheral prostanoid levels and nonsteroidal anti-inflammatory drug analgesia: replicate clinical trials in a tissue injury model. Gordon, S.M., Brahim, J.S., Rowan, J., Kent, A., Dionne, R.A. Clin. Pharmacol. Ther. (2002) [Pubmed]
  37. The effect of ketorolac tromethamine solution 0.5% in reducing postoperative inflammation after cataract extraction and intraocular lens implantation. Flach, A.J., Lavelle, C.J., Olander, K.W., Retzlaff, J.A., Sorenson, L.W. Ophthalmology (1988) [Pubmed]
  38. Premedication with intravenous ketorolac trometamol (Toradol) in colonoscopy: a randomized controlled trial. Mui, W.L., Kwong, W.H., Li, A.C., Au Yeung, A.C., Poon, C.M., Chiu, P.W., Chan, Y.L., Leong, H.T., Ng, E.K. Am. J. Gastroenterol. (2005) [Pubmed]
  39. Lack of efficacy of ketorolac tromethamine for analgesia on patients undergoing colonoscopy. Deal, S.E., Pandak, W.M., Heuman, D.M. Am. J. Gastroenterol. (1993) [Pubmed]
WikiGenes - Universities